Baca berita tanpa iklan. Gabung
June 17, 2021, 06.59 PM

JAKARTA, - Former Health Minister Terawan Agus Putranto said he did not need financial support from the government to develop the homegrown Covid-19 vaccine which is called the Nusantara vaccine

"I understand that the House of Representatives Commission VII has chipped in a huge amount of budget. Frankly, I do not need financial aid from the state," Terawan said in a hearing between the House of Representatives Commission VII and the Covid-19 Research and Innovation Consortium chairman on Wednesday, June 16.  

Instead, Terawan called for the government's political will to approve the controversial Nusantara vaccine as one of the authorized Covid-19 vaccines after it was previously considered not to be used for the Covid-19 vaccination program or to be commercialized in the country. 

Also read: Indonesian Military Denies Support For Controversial Nusantara Vaccine

The vaccine developed by Terawan was previously stipulated in a joint memorandum of understanding between the Health Ministry, the Food and Drug Supervisory Agency (BPOM), and the Indonesian Army for research purposes only.

"What I need is goodwill, political will," he added.

Terawan admitted that he was thunderstruck because the development of the Nusantara vaccine seemed to be hindered. He said the vaccine is safe to use and there have been no victims affected by its development.

"Why would it be hindered? It does not cause death and suffering," he said.

Also read: Indonesia to Use Homegrown Merah Putih Vaccine in Covid-19 Jab Drive

Terawan also asked for the support of Commission VII to allow the Nusantara vaccine clinical trial to resume.

He believed the Nusantara vaccines are safe to use as he and his family had also been injected and did not feel any bad effects.

In addition, the results of the first phase of the clinical trial, he said, showed no signs of virus transmission after people were vaccinated with the Nusantara vaccine.

"I believe that the [Nusantara] vaccine is safe. Dr. Yeti as the examiner said within six months it was very safe and no one was infected from all the results of the third clinical trial patients," he explained.

(Writer: Nicholas Ryan Aditya | Editor : Icha Rastika)


Dapatkan update berita pilihan dan breaking news setiap hari dari Mari bergabung di Grup Telegram " News Update", caranya klik link, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung


Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung
Close Ads